TNF? promotes proliferation of human synovial MSCs while maintaining chondrogenic potential.
Ontology highlight
ABSTRACT: Synovial mesenchymal stem cells (MSCs) are a candidate cell source for cartilage and meniscus regeneration. If we can proliferate synovial MSCs more effectively, we can expand clinical applications to patients with large cartilage and meniscus lesions. TNF? is a pleiotropic cytokine that can affect the growth and differentiation of cells in the body. The purpose of this study was to examine the effect of TNF? on proliferation, chondrogenesis, and other properties of human synovial MSCs. Passage 1 human synovial MSCs from 2 donors were cultured with 2.5 x 10-12~10-7 g/ml, 10 fold dilution series of TNF? for 14 days, then the cell number and colony number was counted. The effect of the optimum dose of TNF? on proliferation was also examined in synovial MSCs from 6 donors. Chondrogenic potential of synovial MSCs pretreated with TNF? was evaluated in 6 donors. The expressions of 12 surface antigens were also examined in 3 donors.2.5 ng/ml and higher concentration of TNF? significantly increased cell number/dish and cell number/colony in both donors. The effect of 25 ng/ml TNF? was confirmed in all 6 donors. There was no significant difference in the weight, or amount of glycosaminoglycan and DNA of the cartilage pellets between the MSCs untreated and MSCs pretreated with 25 ng/ml TNF?. TNF? decreased expression rate of CD 105 and 140b in all 3 donors. TNF? promoted proliferation of synovial MSCs with increase of cell number/ colony. Pretreatment with TNF? did not affect chondrogenesis of synovial MSCs. However, TNF? affected some properties of synovial MSCs.
SUBMITTER: Shioda M
PROVIDER: S-EPMC5461123 | biostudies-literature | 2017
REPOSITORIES: biostudies-literature
ACCESS DATA